Jim Cramer on Structure Therapeutics: “I Don’t Want to Touch It”

Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the stocks on Jim Cramer’s radar recently. When a caller inquired about the stock, Cramer commented:

“Oh, okay, so this is a, they have a deal with Roche, and therefore, I think it’s a legitimate idea, but, boy, the stock fully reflects that deal. I don’t want to touch it. Lilly is still the gold standard.”

Structure Therapeutics Inc. (NASDAQ:GPCR) develops oral small-molecule drugs to treat chronic conditions like obesity and pulmonary fibrosis.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.